FOM Technologies has received an order for our flagship slot-die coating machine from US-based MedTech company. The order is yet another in a series of global MedTech companies that demand FOM’s equipment for advanced materials research.

FOM Technologies is proud to announce the sale of our flagship equipment to a large MedTech customer in the USA. The sale was achieved in cooperation with our American distributor MBraun Inc. and the system is planned for delivery in 2023. The agreement is yet another example of our technology’s possibilities within the MedTech application field.

The company, which wishes to remain anonymous, develops, manufactures and distributes glucose monitoring systems for diabetes treatment. The company operates internationally with headquarters in California and has more than 8,000 employees globally. This investor news will not change the 2023 financial guidance for revenue and EBITDA.